Cancer-Killing virus shows promise in early trial for advanced tumors
Disease control
Recruiting now
This early-phase trial is testing a new treatment called MEM-288, a virus designed to infect and kill cancer cells while also boosting the immune system. The study involves 40 adults with advanced solid tumors, including lung, skin, and breast cancers, who have not responded to s…
Phase: PHASE1 • Sponsor: Memgen, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC